Systematic Review and Meta-Analysis: Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Systematic Review and Meta-Analysis : Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents. / Uhre, Camilla Funch; Uhre, Valdemar Funch; Lønfeldt, Nicole Nadine; Pretzmann, Linea; Vangkilde, Signe; Plessen, Kerstin Jessica; Gluud, Christian; Jakobsen, Janus Christian; Pagsberg, Anne Katrine.

I: Journal of the American Academy of Child and Adolescent Psychiatry, Bind 59, Nr. 1, 01.2020, s. 64-77.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Uhre, CF, Uhre, VF, Lønfeldt, NN, Pretzmann, L, Vangkilde, S, Plessen, KJ, Gluud, C, Jakobsen, JC & Pagsberg, AK 2020, 'Systematic Review and Meta-Analysis: Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents', Journal of the American Academy of Child and Adolescent Psychiatry, bind 59, nr. 1, s. 64-77. https://doi.org/10.1016/j.jaac.2019.08.480

APA

Uhre, C. F., Uhre, V. F., Lønfeldt, N. N., Pretzmann, L., Vangkilde, S., Plessen, K. J., ... Pagsberg, A. K. (2020). Systematic Review and Meta-Analysis: Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 59(1), 64-77. https://doi.org/10.1016/j.jaac.2019.08.480

Vancouver

Uhre CF, Uhre VF, Lønfeldt NN, Pretzmann L, Vangkilde S, Plessen KJ o.a. Systematic Review and Meta-Analysis: Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 2020 jan;59(1):64-77. https://doi.org/10.1016/j.jaac.2019.08.480

Author

Uhre, Camilla Funch ; Uhre, Valdemar Funch ; Lønfeldt, Nicole Nadine ; Pretzmann, Linea ; Vangkilde, Signe ; Plessen, Kerstin Jessica ; Gluud, Christian ; Jakobsen, Janus Christian ; Pagsberg, Anne Katrine. / Systematic Review and Meta-Analysis : Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents. I: Journal of the American Academy of Child and Adolescent Psychiatry. 2020 ; Bind 59, Nr. 1. s. 64-77.

Bibtex

@article{e2dd81abf04d4b259d77d3fdd010dd12,
title = "Systematic Review and Meta-Analysis: Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents",
abstract = "Objective: To assess benefits and harms of cognitive-behavioral therapy (CBT) versus no intervention or versus other interventions for pediatric obsessive-compulsive disorder (OCD). Method: We searched for randomized clinical trials of CBT for pediatric OCD. Primary outcomes were OCD severity, serious adverse events, and level of functioning. Secondary outcomes were quality of life and adverse events. Remission from OCD was included as an exploratory outcome. We assessed risk of bias and evaluated the certainty of the evidence with the Grading of Recommendations Assessment, Development and Evaluation (GRADE). Results: Nine trials (N = 645) were included comparing CBT with no intervention and 3 trials (N = 146) comparing CBT with selective serotonin reuptake inhibitors (SSRIs). Compared with no intervention, CBT decreased OCD severity (mean difference [MD] = −8.51, 95{\%} CI = −10.84 to −6.18, p < .00001, low certainty), improved level of functioning (patient-rated: standardized MD [SMD] = −0.90, 95{\%} CI = −1.19 to −0.62, p < .00001, very low certainty; parent-rated: SMD = −0.68, 95{\%} CI = −1.12 to −0.23, p = .003, very low certainty), had similar proportions of participants with adverse events (risk ratio = 1.06, 95{\%} CI = 0.93−1.22, p = .39, GRADE: low certainty), and was associated with reduced risk of still having OCD (risk ratio = 0.50, 95{\%} CI = 0.37−0.67, p < .00001, very low certainty). We had insufficient data to assess the effect of CBT versus no intervention on serious adverse events and quality of life. Compared with SSRIs, CBT led to similar decreases in OCD severity (MD = −0.75, 95{\%} CI = −3.79 to 2.29, p = .63, GRADE: very low certainty), and was associated with similar risk of still having OCD (risk ratio = 0.85, 95{\%} CI = 0.66−1.09, p = .20, very low certainty). We had insufficient data to assess the effect of CBT versus SSRIs on serious adverse events, level of functioning, quality of life, and adverse events. Conclusion: CBT may be more effective than no intervention and comparable to SSRIs for pediatric OCD, but we are very uncertain about the effect estimates.",
keywords = "cognitive-behavioral therapy, obsessive-compulsive disorder, systematic review",
author = "Uhre, {Camilla Funch} and Uhre, {Valdemar Funch} and L{\o}nfeldt, {Nicole Nadine} and Linea Pretzmann and Signe Vangkilde and Plessen, {Kerstin Jessica} and Christian Gluud and Jakobsen, {Janus Christian} and Pagsberg, {Anne Katrine}",
year = "2020",
month = "1",
doi = "10.1016/j.jaac.2019.08.480",
language = "English",
volume = "59",
pages = "64--77",
journal = "American Academy of Child and Adolescent Psychiatry. Journal",
issn = "0890-8567",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Systematic Review and Meta-Analysis

T2 - Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents

AU - Uhre, Camilla Funch

AU - Uhre, Valdemar Funch

AU - Lønfeldt, Nicole Nadine

AU - Pretzmann, Linea

AU - Vangkilde, Signe

AU - Plessen, Kerstin Jessica

AU - Gluud, Christian

AU - Jakobsen, Janus Christian

AU - Pagsberg, Anne Katrine

PY - 2020/1

Y1 - 2020/1

N2 - Objective: To assess benefits and harms of cognitive-behavioral therapy (CBT) versus no intervention or versus other interventions for pediatric obsessive-compulsive disorder (OCD). Method: We searched for randomized clinical trials of CBT for pediatric OCD. Primary outcomes were OCD severity, serious adverse events, and level of functioning. Secondary outcomes were quality of life and adverse events. Remission from OCD was included as an exploratory outcome. We assessed risk of bias and evaluated the certainty of the evidence with the Grading of Recommendations Assessment, Development and Evaluation (GRADE). Results: Nine trials (N = 645) were included comparing CBT with no intervention and 3 trials (N = 146) comparing CBT with selective serotonin reuptake inhibitors (SSRIs). Compared with no intervention, CBT decreased OCD severity (mean difference [MD] = −8.51, 95% CI = −10.84 to −6.18, p < .00001, low certainty), improved level of functioning (patient-rated: standardized MD [SMD] = −0.90, 95% CI = −1.19 to −0.62, p < .00001, very low certainty; parent-rated: SMD = −0.68, 95% CI = −1.12 to −0.23, p = .003, very low certainty), had similar proportions of participants with adverse events (risk ratio = 1.06, 95% CI = 0.93−1.22, p = .39, GRADE: low certainty), and was associated with reduced risk of still having OCD (risk ratio = 0.50, 95% CI = 0.37−0.67, p < .00001, very low certainty). We had insufficient data to assess the effect of CBT versus no intervention on serious adverse events and quality of life. Compared with SSRIs, CBT led to similar decreases in OCD severity (MD = −0.75, 95% CI = −3.79 to 2.29, p = .63, GRADE: very low certainty), and was associated with similar risk of still having OCD (risk ratio = 0.85, 95% CI = 0.66−1.09, p = .20, very low certainty). We had insufficient data to assess the effect of CBT versus SSRIs on serious adverse events, level of functioning, quality of life, and adverse events. Conclusion: CBT may be more effective than no intervention and comparable to SSRIs for pediatric OCD, but we are very uncertain about the effect estimates.

AB - Objective: To assess benefits and harms of cognitive-behavioral therapy (CBT) versus no intervention or versus other interventions for pediatric obsessive-compulsive disorder (OCD). Method: We searched for randomized clinical trials of CBT for pediatric OCD. Primary outcomes were OCD severity, serious adverse events, and level of functioning. Secondary outcomes were quality of life and adverse events. Remission from OCD was included as an exploratory outcome. We assessed risk of bias and evaluated the certainty of the evidence with the Grading of Recommendations Assessment, Development and Evaluation (GRADE). Results: Nine trials (N = 645) were included comparing CBT with no intervention and 3 trials (N = 146) comparing CBT with selective serotonin reuptake inhibitors (SSRIs). Compared with no intervention, CBT decreased OCD severity (mean difference [MD] = −8.51, 95% CI = −10.84 to −6.18, p < .00001, low certainty), improved level of functioning (patient-rated: standardized MD [SMD] = −0.90, 95% CI = −1.19 to −0.62, p < .00001, very low certainty; parent-rated: SMD = −0.68, 95% CI = −1.12 to −0.23, p = .003, very low certainty), had similar proportions of participants with adverse events (risk ratio = 1.06, 95% CI = 0.93−1.22, p = .39, GRADE: low certainty), and was associated with reduced risk of still having OCD (risk ratio = 0.50, 95% CI = 0.37−0.67, p < .00001, very low certainty). We had insufficient data to assess the effect of CBT versus no intervention on serious adverse events and quality of life. Compared with SSRIs, CBT led to similar decreases in OCD severity (MD = −0.75, 95% CI = −3.79 to 2.29, p = .63, GRADE: very low certainty), and was associated with similar risk of still having OCD (risk ratio = 0.85, 95% CI = 0.66−1.09, p = .20, very low certainty). We had insufficient data to assess the effect of CBT versus SSRIs on serious adverse events, level of functioning, quality of life, and adverse events. Conclusion: CBT may be more effective than no intervention and comparable to SSRIs for pediatric OCD, but we are very uncertain about the effect estimates.

KW - cognitive-behavioral therapy

KW - obsessive-compulsive disorder

KW - systematic review

U2 - 10.1016/j.jaac.2019.08.480

DO - 10.1016/j.jaac.2019.08.480

M3 - Review

C2 - 31589909

AN - SCOPUS:85075875098

VL - 59

SP - 64

EP - 77

JO - American Academy of Child and Adolescent Psychiatry. Journal

JF - American Academy of Child and Adolescent Psychiatry. Journal

SN - 0890-8567

IS - 1

ER -

ID: 236721617